Lantheus gets FDA approval for drug manufacturing facility in Billerica
Lantheus Holdings has secured approval from the US Food and Drug Administration (FDA) for the supplemental drug application (sNDA) for its isolator-based drug manufacturing facility for DEFINITY (Perflutren Lipid Microsphere) in North Billerica, Massachusetts. According to the US-based provider of diagnostic imaging agents, DEFINITY is an ultrasound enhancing agent in the US for patients having […]